Leading policy-makers and scholars explain how market forces, deregulation, and consumer choice can work to improve health care for all Americans.


Evaluating Doctors with Medicare Data
The New York Times, 4-12-04

The New York Times weighs in with a thoughtful editorial advocating that Medicare release more data on physician quality, albeit with safeguards to ensure that physicians who treat sicker patients or more complex ailments aren't penalized for their efforts.

The federal Medicare program is sitting on a trove of information that could help employers and patients decide which doctors provide the best service at the most reasonable cost. This is precisely the sort of information that President Bush has been urging the health care system to make available so that consumers can choose their doctors wisely. Yet the Department of Health and Human Services, relying on an old and dated court decision, has turned down a request for the data.

The conflicting perspectives were described by Robert Pear in yesterday's Times. The Business Roundtable, which represents 160 large companies, asked Medicare to release data on payments to individual physicians to help them determine which doctors achieved the best results—performing the most knee operations with the fewest complications and deaths, for example—and how the average cost per case differs from doctor to doctor.

Releasing the information would help insurance plans and employers decide which doctors to include in their networks. Properly scrubbed and evaluated, the information could also help patients choose their doctors.

To be sure, the raw data could be confusing. Individual doctors may have too few patients with a given diagnosis to yield trustworthy statistics, or their patients may be atypical; they may look good by one measure but bad by another. Medicare is running pilot programs to test releasing the data for physicians along with other measures of cost and quality, and it needs to be presented in ways that are fair to the doctors and useful to patients.

Project FDA.
home   spotlight   commentary   research   events   news   about   contact   links   archives
Copyright Manhattan Institute for Policy Research
52 Vanderbilt Avenue
New York, NY 10017
(212) 599-7000